As of 2026-07-08, the Relative Valuation of Biogen Inc (BIIB) is 235.83 USD. This relative valuation is based on P/E multiples. With the latest stock price at 208.46 USD, the upside of Biogen Inc based on Relative Valuation is 13.1%.
The range of the Relative Valuation is 215.21 - 276.16 USD.
| Range | Selected | |
| Trailing P/E multiples | 23.2x - 29.7x | 26.2x |
| Forward P/E multiples | 24.4x - 28.1x | 24.8x |
| Fair Price | 215.21 - 276.16 | 235.83 |
| Upside | 3.2% - 32.5% | 13.1% |
| Date | P/E |
| 2026-07-07 | 22.14 |
| 2026-07-06 | 22.43 |
| 2026-07-02 | 23.26 |
| 2026-07-01 | 22.57 |
| 2026-06-30 | 23.25 |
| 2026-06-29 | 23.31 |
| 2026-06-26 | 23.25 |
| 2026-06-25 | 21.73 |
| 2026-06-24 | 21.48 |
| 2026-06-23 | 21.22 |
| 2026-06-22 | 21.49 |
| 2026-06-18 | 21.16 |
| 2026-06-17 | 21.38 |
| 2026-06-16 | 21.05 |
| 2026-06-15 | 21.38 |
| 2026-06-12 | 21.53 |
| 2026-06-11 | 21.52 |
| 2026-06-10 | 20.90 |
| 2026-06-09 | 21.43 |
| 2026-06-08 | 20.73 |
| 2026-06-05 | 21.02 |
| 2026-06-04 | 21.14 |
| 2026-06-03 | 21.09 |
| 2026-06-02 | 20.32 |
| 2026-06-01 | 20.69 |
| 2026-05-29 | 21.09 |
| 2026-05-28 | 21.13 |
| 2026-05-27 | 21.20 |
| 2026-05-26 | 20.78 |
| 2026-05-22 | 20.85 |
| 2026-05-21 | 20.39 |
| 2026-05-20 | 20.21 |
| 2026-05-19 | 20.51 |
| 2026-05-18 | 20.65 |
| 2026-05-15 | 20.76 |
| 2026-05-14 | 20.59 |
| 2026-05-13 | 22.01 |
| 2026-05-12 | 21.45 |
| 2026-05-11 | 21.30 |
| 2026-05-08 | 20.82 |
| 2026-05-07 | 20.60 |
| 2026-05-06 | 20.52 |
| 2026-05-05 | 20.35 |
| 2026-05-04 | 20.15 |
| 2026-05-01 | 20.13 |
| 2026-04-30 | 20.37 |
| 2026-04-29 | 20.92 |
| 2026-04-28 | 19.73 |
| 2026-04-27 | 19.44 |
| 2026-04-24 | 19.84 |